N-acetylglucosaminyltransferase III expression in lower eukaryotes

Details for Australian Patent Application No. 2004213859 (hide)

Owner GlycoFi, Inc.

Inventors Nett, Juergen Hermann; Choi, ByungKwon; Bobrowicz, Piotr; Gerngross, Tillman U.; Davidson, Robert C.; Wildt, Stefan; Hamilton, Stephen R.

Agent Cullens

Pub. Number AU-B-2004213859

PCT Pub. Number WO2004/074458

Priority 10/680,963 07.10.03 US; 10/371,877 20.02.03 US

Filing date 20 February 2004

Wipo publication date 2 September 2004

Acceptance publication date 7 January 2010

International Classifications

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

C12P 21/00 (2006.01) Preparation of peptides or proteins

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/074458 Priority application(s): WO2004/074458

2 February 2006 Assignment before Grant

  Hamilton, Stephen; Bobrowicz, Piotr; Wildt, Stefan; Choi, Byung-Kwon; Nett, Juergen; Davidson, Robert; Gerngross, Tillman The application has been assigned to GlycoFi, Inc.

7 January 2010 Application Accepted

  Published as AU-B-2004213859

6 May 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004213860-Endomannosidases in the modification of glycoproteins in eukaryotes

2004213858-Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions